Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 15, 2018
The Pulmonary Fibrosis Associated MUC5B Promoter Polymorphism Is Prognostic of the Overall Survival in Patients with Non-Small Cell Lung Cancer (NSCLC) Receiving Definitive Radiotherapy.
Journal: Translational oncology
Published: November 16, 2016
Sparing of normal tissues with volumetric arc radiation therapy for glioblastoma: single institution clinical experience.
Journal: Radiation oncology (London, England)
Published: November 15, 2016
Patient-reported Urinary, Bowel, and Sexual Function After Hypofractionated Intensity-modulated Radiation Therapy for Prostate Cancer: Results From a Randomized Trial.
Journal: American journal of clinical oncology
Published: September 17, 2016
Select men benefit from androgen deprivation therapy delivered with salvage radiation therapy after prostatectomy.
Journal: Prostate cancer and prostatic diseases
Published: August 08, 2016
Prognostic Factors as a Function of Disease-free Interval After Definitive (Chemo)radiation for Non-Small Cell Lung Cancer Using Conditional Survival Analysis.
Journal: American journal of clinical oncology
Published: November 05, 2015
Survival and toxicity following sequential multimodality treatment including whole abdominopelvic radiotherapy for patients with desmoplastic small round cell tumor.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: June 13, 2015
Long-term outcomes after proton therapy, with concurrent chemotherapy, for stage II-III inoperable non-small cell lung cancer.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: December 17, 2014
Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model.
Journal: Breast cancer research : BCR
Published: September 19, 2014
Use of simultaneous radiation boost achieves high control rates in patients with non-small-cell lung cancer who are not candidates for surgery or conventional chemoradiation.
Journal: Clinical lung cancer
Published: August 29, 2014
Serum inflammatory miRNAs predict radiation esophagitis in patients receiving definitive radiochemotherapy for non-small cell lung cancer.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: August 28, 2014
Last Updated: 09/26/2026